The US Securities and Exchange Commission (SEC) is investigating a possible case of insider trading involving the Centers for Medicare and Medicaid Services (CMS) and the biotechnology company Dendreon Corporation (DNDN).
The US Securities and Exchange Commission (SEC) is investigating a possible case of insider trading involving the Centers for Medicare and Medicaid Services (CMS) and the biotechnology company Dendreon Corporation (DNDN).
Share this Article
Comment on this Article
Recommended
Please to comment